S-TRAC trial: Sensitivity analyses of disease-free survival (DFS).

被引：0
|
作者：
George, Daniel J.
Pantuck, Allan J.
Motzer, Robert J.
Ravaud, Alain
Escudier, Bernard
Staehler, Michael D.
Serfass, Lucile
Krishnaswami, Sriram
Casey, Michelle
Lechuga, Mariajose
Koch, Gary
Figlin, Robert A.
机构：
[1] Duke Univ, Duke Canc Inst, Durham, NC USA
[2] Univ Calif Los Angeles, Inst Urol Oncol, David Geffen Sch Med, Los Angeles, CA USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY USA
[4] Bordeaux Univ Hosp, Hop St Andre, Bordeaux, France
[5] Inst Gustave Roussy, Villejuif, France
[6] Ludwig Maximilians Univ Munchen, Univ Hosp Munich Grosshadern, Munich, Germany
[7] Pfizer Oncology Inc, Paris, France
[8] Pfizer, New York, NY USA
[9] Pfizer Inc, Collegeville, PA USA
[10] Pfizer Srl, Milan, Italy
[11] Univ North Carolina Chapel Hill, Chapel Hill, NC USA
[12] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.633
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
633
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Disease-free survival (DFS) and distant metastasis-free survival (DMFS) as surrogates for overall survival (OS) in adjuvant treatment of muscle-invasive bladder cancer (MIBC)
    Sternberg, C.
    Squifflet, P.
    Burdett, S.
    Fisher, D.
    Saad, E. D.
    Kurt, M.
    Teitsson, S.
    May, J. R.
    Stoeckle, M.
    Torti, F.
    Cote, R.
    Groshen, S.
    Ruggeri, E.
    Zhegalik, A.
    Tierney, J.
    Collette, L.
    Burzykowski, T.
    Buyse, M. E.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1335 - S1336
  • [22] Association of a genomic index of sensitivity to endocrine therapy with disease-free survival in breast cancer
    Singh, P.
    Bedrosian, I.
    Ha, M. J.
    Shen, Y.
    Du, L.
    Gould, R.
    Symmans, F.
    ANNALS OF ONCOLOGY, 2020, 31 : S32 - S32
  • [23] Understanding the adverse event experience in the S-TRAC adjuvant trial of sunitinib for high-risk renal cell carcinoma
    Wood, Sarah Yenser
    Ryan, Joanne C.
    Clair, Andrew G.
    George, Daniel J.
    FUTURE ONCOLOGY, 2020, 16 (04) : 39 - 47
  • [24] Clinical significance of hepatic resection in hepato-cellular carcinoma (HCC), analyzed by disease-free survival (DFS) curves.
    Sakon, M
    Umeshita, K
    Nagano, H
    Yamada, T
    Eguchi, H
    Kishimoto, S
    Miyamoto, A
    Taniguchi, K
    Dohno, K
    Nakamori, S
    Gotoh, M
    Monden, M
    GASTROENTEROLOGY, 1998, 114 (04) : A1331 - A1331
  • [25] Prognostic efficacy of the human B-cell lymphoma prognostic genes in predicting disease-free survival (DFS) in the canine counterpart
    Zamani-Ahmadmahmudi, Mohamad
    Aghasharif, Sina
    Ilbeigi, Keyhan
    BMC VETERINARY RESEARCH, 2017, 13
  • [26] External validation of a nomogram predicting disease-free (DFS) and overall survival (OS) in patients (pts) with primary retroperitoneal sarcoma (pRPS)
    Raut, C.
    Miceli, R.
    Strauss, D.
    Swallow, C.
    Hohenberger, P.
    Van Coevorden, F.
    Rutkowski, P.
    Fiore, M.
    Callegaro, D.
    Casali, P.
    Haas, R.
    Hayes, A.
    Honore, C.
    Cannell, A.
    Jakob, J.
    Szacht, M.
    Fairweather, M.
    Pollock, R.
    Bonvalot, S.
    Gronchi, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S689 - S690
  • [27] Prognostic efficacy of the human B-cell lymphoma prognostic genes in predicting disease-free survival (DFS) in the canine counterpart
    Mohamad Zamani-Ahmadmahmudi
    Sina Aghasharif
    Keyhan Ilbeigi
    BMC Veterinary Research, 13
  • [28] The FLAME trial: benefit of a focal boost for prostate cancer on biochemical disease-free survival
    Kerkmeijer, L. G. W.
    Groen, V. H.
    Pos, F. J.
    Haustermans, K.
    Monninkhof, E. M.
    Smeenk, R. J.
    Kunze-Busch, M. C.
    De Boer, H. C. J.
    Van Zyp, J. R. N. Van der Voort
    Van Vulpen, M.
    Draulans, C.
    Van den Bergh, L.
    Isebaert, S.
    Van der Heide, U. A.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S347 - S348
  • [29] miR-31 as a prognostic and predictive marker of disease-free survival (DFS) in resected stage III colon cancer: A retrospective analysis of the PETACC-8 trial
    Mathe, Y. Gaston
    Martin-Lanneree, S.
    Vazart, C.
    Fontaine, K.
    Mulot, C.
    Caumont, A.
    Montestruc, F.
    Le Malicot, K.
    Lepage, C.
    Taieb, J.
    Laurent-Puig, P.
    ANNALS OF ONCOLOGY, 2018, 29 : 175 - 175
  • [30] Postoperative Complications Compromised Disease-Free and Recurrence-Free Survival in CALGB 140503 Trial Patients
    Miller, D. L.
    Wang, X.
    Damman, B.
    Mentlick, J.
    Landreneau, R.
    Wigle, D.
    Jones, D.
    Conti, M.
    Ashrafi, A.
    Liberman, M.
    Port, J.
    de Perrot, M.
    Mitchell, J.
    Keenan, R.
    Bauer, T.
    Stinchcombe, T.
    Altorki, N.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S64 - S65
12345